Hormonal regulation of food intake.

Our knowledge of the physiological systems controlling energy homeostasis has increased dramatically over the last decade. The roles of peripheral signals from adipose tissue, pancreas, and the gastrointestinal tract reflecting short- and long-term nutritional status are now being described. Such signals influence central circuits in the hypothalamus, brain stem, and limbic system to modulate neuropeptide release and hence food intake and energy expenditure. This review discusses the peripheral hormones and central neuronal pathways that contribute to control of appetite.

[1]  H. Grill,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society The Role of the Dorsal Vagal Complex and the Vagus Nerve in Feeding Effects of Melanocortin-3/4 Receptor Stimulation* , 2022 .

[2]  J. Hebebrand,et al.  Ghrelin gene: identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  Motonao Nakamura,et al.  Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Rogers,et al.  Hyperphagia in pre-fed rats following oral delta9-THC. , 1998, Physiology & behavior.

[5]  R. Palmiter,et al.  Leptin-regulated endocannabinoids are involved in maintaining food intake , 2001, Nature.

[6]  I. Sumaya,et al.  The effect of hypothalamic peptide YY on hippocampal acetylcholine release in vivo: implications for limbic function in binge-eating behavior , 1998, Brain Research.

[7]  C. Mantzoros,et al.  Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. , 2002, Diabetes.

[8]  S. Woods,et al.  Inhibition of hypothalamic neuropeptide Y gene expression by insulin. , 1992, Endocrinology.

[9]  S. O’Rahilly,et al.  Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. , 2002, Endocrinology.

[10]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[11]  R. Reidelberger,et al.  Comparative effects of CCK-8 on feeding, sham feeding, and exocrine pancreatic secretion in rats. , 1986, The American journal of physiology.

[12]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[13]  M. Maayan,et al.  Gold thioglucose obesity syndrome. , 1977, Federation proceedings.

[14]  H. Akil,et al.  Evidence that β-endorphin is synthesized in cells in the nucleus tractus solitarius: detection of POMC mRNA , 1992, Brain Research.

[15]  M. Greenwood,et al.  Infusion of cholecystokinin between meals into free-feeding rats fails to prolong the intermeal interval , 1987, Physiology & Behavior.

[16]  J. Holst,et al.  Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. , 1983, International journal of obesity.

[17]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[18]  C. Flachskamm,et al.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. , 2003, The Journal of clinical investigation.

[19]  S. Woods,et al.  Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice , 1996, Diabetes.

[20]  G. Frost,et al.  Ghrelin enhances appetite and increases food intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[21]  D. Porte,et al.  Leptin and insulin action in the central nervous system. , 2002, Nutrition reviews.

[22]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[23]  P. Shizgal,et al.  Modulation of brain reward circuitry by leptin. , 2000, Science.

[24]  W. Chung,et al.  Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts. , 1997, Genomics.

[25]  J. Miyazaki,et al.  Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. , 1999, Gastroenterology.

[26]  K. Fuxe,et al.  NPY Y1 receptor like immunoreactivity exists in a subpopulation of β-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat , 1997, Neuroscience Letters.

[27]  R. Krauss,et al.  Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Kirkham,et al.  Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors , 1999, Psychopharmacology.

[29]  S. Bloom,et al.  Food fails to suppress ghrelin levels in obese humans. , 2002, The Journal of clinical endocrinology and metabolism.

[30]  C. Strader,et al.  Diet-induced obese mice develop peripheral, but not central, resistance to leptin. , 1997, The Journal of clinical investigation.

[31]  L. Storlien,et al.  Altered levels of POMC, AgRP and MC4-R mRNA expression in the hypothalamus and other parts of the limbic system of mice prone or resistant to chronic high-energy diet-induced obesity , 2003, Brain Research.

[32]  W. Hanif,et al.  Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. , 2004, Metabolism: clinical and experimental.

[33]  H. Ogura,et al.  Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity , 1997, Nature.

[34]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[35]  S. Woods,et al.  Intraventricular insulin reduces food intake and body weight of lean but not obese zucker rats , 1986, Appetite.

[36]  S. Bloom,et al.  The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. , 1999, The Journal of endocrinology.

[37]  D. Larhammar.  Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide , 1996, Regulatory Peptides.

[38]  H. Bays,et al.  Pharmacotherapy of Obesity , 2002, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[39]  S. Leibowitz,et al.  Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion , 1985, Peptides.

[40]  R. Cone,et al.  Ala67Thr polymorphism in the Agouti‐related peptide gene is associated with inherited leanness in humans , 2004, American journal of medical genetics. Part A.

[41]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[42]  A. Strosberg,et al.  A leptin missense mutation associated with hypogonadism and morbid obesity , 1998, Nature Genetics.

[43]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[44]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[45]  K. Fujioka,et al.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. , 1999, JAMA.

[46]  M. Low,et al.  Selective reward deficit in mice lacking beta-endorphin and enkephalin. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  K. Fuxe,et al.  Receptor autoradiographical evidence for high densities of 125I-neuropeptide Y binding sites in the nucleus tractus solitarius of the normal male rat. , 1986, Acta physiologica Scandinavica.

[48]  L. Orci,et al.  Pancreatic polypeptide: A possible role in the regulation of food intake in the mouse. Hypothesis , 1977, Experientia.

[49]  B. Wisse,et al.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. , 2001, Diabetes.

[50]  W. Millington,et al.  Detection of Pro-Opiomelanocortin mRNA in Human and Rat Caudal Medulla by RT-PCR , 1998, Peptides.

[51]  J. Morley,et al.  Effect of centrally administered neurotensin on multiple feeding paradigms , 1983, Pharmacology Biochemistry and Behavior.

[52]  M. Tamai,et al.  Expression of Cytokine Genes in a Patient with Conjunctival Melanoma Compared with Other Pigment Cells , 1998, Ophthalmic Research.

[53]  M. Tschöp,et al.  Post-prandial decrease of circulating human ghrelin levels , 2001, Journal of endocrinological investigation.

[54]  Sarah M. Williams,et al.  Melanocortin 4 Receptor-Mediated Hyperphagia and Activation of Neuropeptide Y Expression in the Dorsomedial Hypothalamus during Lactation , 2004, The Journal of Neuroscience.

[55]  S. O’Rahilly,et al.  Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. , 2003, Biochemical and biophysical research communications.

[56]  L. Swanson,et al.  The organization and biochemical specificity of afferent projections to the paraventricular and supraoptic nuclei. , 1983, Progress in brain research.

[57]  S. Zolotukhin,et al.  Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Joanne A Harrold,et al.  Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. , 2005, Current drug targets.

[59]  D. Macneil,et al.  Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. , 2004, Endocrinology.

[60]  M. Schwartz,et al.  Elevated plasma ghrelin levels in Prader–Willi syndrome , 2002, Nature Medicine.

[61]  R. Ahima,et al.  Adiponectin acts in the brain to decrease body weight , 2004, Nature Medicine.

[62]  A. Kelley,et al.  Enhanced intake of high-fat food following striatal mu-opioid stimulation: microinjection mapping and Fos expression , 2000, Neuroscience.

[63]  R. Quirion,et al.  Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain , 1998, The Journal of Neuroscience.

[64]  T. Hökfelt,et al.  Hypocretin/Orexin‐ and melanin‐concentrating hormone‐expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene‐related protein systems , 1998, The Journal of comparative neurology.

[65]  R. Cone,et al.  The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. , 2004, Recent progress in hormone research.

[66]  M. Kasuga,et al.  Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa , 1997, Biological Psychiatry.

[67]  F. Sundler,et al.  Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells , 2004, Cell and Tissue Research.

[68]  M. White,et al.  Insulin receptor substrate-1 (IRS-1) expression in rat brain. , 1994, Endocrinology.

[69]  R. Klein,et al.  Role of brain insulin receptor in control of body weight and reproduction. , 2006, Science.

[70]  Bernd Fritzsch,et al.  Abdominal vagal mediation of the satiety effects of CCK in rats. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[71]  S. Sarkar,et al.  Central Administration of Neuropeptide Y Reduces α-Melanocyte-Stimulating Hormone-Induced Cyclic Adenosine 5′-Monophosphate Response Element Binding Protein (CREB) Phosphorylation in Pro-Thyrotropin-Releasing Hormone Neurons and Increases CREB Phosphorylation in Corticotropin-Releasing Hormone Neuro , 2003 .

[72]  M. Nakazato,et al.  Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. , 2002, The Journal of endocrinology.

[73]  J. Kamegai,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society doi: 10.1210/en.2002-220268 Ghrelin Stimulates GH But Not Food Intake in Arcuate Nucleus Ablated Rats , 2022 .

[74]  R. Jaenisch,et al.  Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. , 2001, Molecular endocrinology.

[75]  S. Bloom,et al.  GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN , 1987, The Lancet.

[76]  J. Koch.  Δ9-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets , 2001, Pharmacology Biochemistry and Behavior.

[77]  P. Rogers,et al.  Hyperphagia in pre-fed rats following oral δ9-THC , 1998, Physiology & Behavior.

[78]  A. Young,et al.  Effects of PYY[3–36] in rodent models of diabetes and obesity , 2004, International Journal of Obesity.

[79]  N. Vrang,et al.  Glucagon-like peptide containing pathways in the regulation of feeding behaviour , 2001, International Journal of Obesity.

[80]  Philippe Froguel,et al.  Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.

[81]  S. O’Rahilly,et al.  Peptide YY3-36 and satiety: clarity or confusion? , 2004, Endocrinology.

[82]  D. Conze,et al.  Feeding after fourth ventricular administration of neuropeptide Y receptor agonists in rats , 2001, Peptides.

[83]  K. Polonsky,et al.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.

[84]  L. Tartaglia,et al.  The Leptin Receptor* , 1997, The Journal of Biological Chemistry.

[85]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[86]  B. Vialettes,et al.  Low Plasma Levels of Pancreatic Polypeptide in Obesity , 1980, Diabetes.

[87]  D. Smith,et al.  Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. , 1997, Endocrinology.

[88]  E. Arenas,et al.  Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor , 1999, Nature Medicine.

[89]  S. Gammeltoft,et al.  A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.

[90]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[91]  S. Leibowitz,et al.  Stimulation of feeding by galanin: Anatomical localization and behavioral specificity of this peptide's effects in the brain , 1990, Peptides.

[92]  N. Scopinaro,et al.  Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. , 1981, International journal of obesity.

[93]  C. Ronchi,et al.  Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. , 2003, The Journal of clinical endocrinology and metabolism.

[94]  T. Funahashi,et al.  Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. , 2001, Diabetes.

[95]  S. Bloom,et al.  Increased Neuropeptide Y Concentrations in Specific Hypothalamic Regions of Streptozocin-Induced Diabetic Rats , 1989, Diabetes.

[96]  E. Theodorsson,et al.  Pharmacokinetic profile of orexin A and effects on plasma insulin and glucagon in the rat , 2004, Regulatory Peptides.

[97]  G. Schwartz,et al.  Neurobiology of cholecystokinin. , 1994, Critical reviews in neurobiology.

[98]  P. J. Larsen,et al.  Hypothalamic CART is a new anorectic peptide regulated by leptin , 1998, Nature.

[99]  Min-Seon Kim,et al.  Investigation of the melanocyte stimulating hormones on food intake Lack of evidence to support a role for the melanocortin-3-receptor , 2000, Brain Research.

[100]  K. Pienta,et al.  Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance. , 1988, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[101]  T. Hökfelt,et al.  The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[102]  R. Batterham,et al.  Ghrelin causes hyperphagia and obesity in rats. , 2001, Diabetes.

[103]  K. Rudolf,et al.  Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents , 1998, British journal of pharmacology.

[104]  M. Tschöp,et al.  Ghrelin induces adiposity in rodents , 2000, Nature.

[105]  B. Glenn Stanley,et al.  Brain regions where cholecystokinin suppresses feeding in rats , 2000, Brain Research.

[106]  A. Prentice,et al.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency. , 1999, The New England journal of medicine.

[107]  W. Weiss.  Pharmacotherapy for obesity. , 2002, The New England journal of medicine.

[108]  S. Woods,et al.  Localization of 125I-insulin binding sites in the rat hypothalamus by quantitative autoradiography , 1986, Neuroscience Letters.

[109]  C. Plata-salamán,et al.  Disordered food intake and obesity in rats lacking cholecystokinin A receptors. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[110]  M. Nakazato,et al.  A role for ghrelin in the central regulation of feeding , 2001, Nature.

[111]  B. Göke,et al.  Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. , 1995, Digestion.

[112]  C. Beglinger,et al.  Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[113]  C. Saper,et al.  The Need to Feed Homeostatic and Hedonic Control of Eating , 2002, Neuron.

[114]  S. Bloom,et al.  A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. , 1998, Endocrinology.

[115]  A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Regulatory Peptides.

[116]  M. Heilig,et al.  Diverse functions of neuropeptide Y revealed using genetically modified animals , 2002, Neuropeptides.

[117]  D. Atrens,et al.  Insulin and the paraventricular hypothalamus: modulation of energy balance , 1991, Brain Research.

[118]  R. Coffey,et al.  Stimulatory Actions of Insulin-Like Growth Factor-I and Transforming Growth Factor-α on Intestinal Neurotensin and Peptide YY1. , 1999, Endocrinology.

[119]  M. I. Smith,et al.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[120]  R. Skoda,et al.  Leptin Receptor Immunoreactivity in Chemically Defined Target Neurons of the Hypothalamus , 1998, The Journal of Neuroscience.

[121]  M. Wood,et al.  Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor. , 2000, European journal of pharmacology.

[122]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[123]  G. Schwartz,et al.  Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[124]  M. Schwartz,et al.  Effect of Intracerebroventricular Insulin Infusion on Diabetic Hyperphagia and Hypothalamic Neuropeptide Gene Expression , 1995, Diabetes.

[125]  S. Leibowitz,et al.  Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity , 1986, Peptides.

[126]  C. Beglinger,et al.  Two molecular forms of Peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1–36 and PYY 3–36 , 1994, Regulatory Peptides.

[127]  G. Frost,et al.  Pancreatic polypeptide reduces appetite and food intake in humans. , 2003, The Journal of clinical endocrinology and metabolism.

[128]  M. Ghatei,et al.  Hypothalamic Interactions Between Neuropeptide Y, Agouti‐Related Protein, Cocaine‐ and Amphetamine‐Regulated Transcript and Alpha‐Melanocyte‐Stimulating Hormone In Vitro in Male Rats , 2002, Journal of neuroendocrinology.

[129]  Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake. , 1996, Endocrinology.

[130]  H. Lodish,et al.  ACRP30, a new hormone controlling fat and glucose metabolism. , 2002, European journal of pharmacology.

[131]  M. Low,et al.  Selective Reward Deficit in Mice Lacking β-Endorphin and Enkephalin , 2002, The Journal of Neuroscience.

[132]  P. Widdowson,et al.  Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding. , 1999, Diabetes.

[133]  K. Huse,et al.  Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. , 2004, The Journal of clinical endocrinology and metabolism.

[134]  J. Conlon.  The origin and evolution of peptide YY (PYY) and pancreatic polypeptide (PP) , 2002, Peptides.

[135]  P. Leung,et al.  Ghrelin, a novel placental-derived hormone. , 2001 .

[136]  J. Critchley,et al.  Effects of nalmefene on feeding in humans , 1990, Psychopharmacology.

[137]  Hui Zheng,et al.  Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[138]  R. McLeod,et al.  Human pancreatic polypeptide: studies of fasting and postprandial plasma concentrations. , 1980, Canadian journal of physiology and pharmacology.

[139]  E. Berry,et al.  Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. , 2000, European journal of pharmacology.

[140]  D. Porte,et al.  The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. , 1967, The Journal of clinical investigation.

[141]  C. Baile,et al.  Obese mice and the satiety effects of cholecystokinin, bombesin and pancreatic polypeptide , 1981, Physiology & Behavior.

[142]  C. Picó,et al.  The inhibition of gastric ghrelin production by food intake in rats is dependent on the type of macronutrient. , 2004, Endocrinology.

[143]  B. Levin,et al.  Reduced central leptin sensitivity in rats with diet-induced obesity. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[144]  S. Bloom,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Evidence of an Orexigenic Role for Cocaine- and Amphetamine-Regulated Transcript after Administration into Discrete Hypothalamic Nuclei , 2022 .

[145]  R. Jensen,et al.  Characterization of bombesin binding sites in the rat stomach. , 1997, European journal of pharmacology.

[146]  M. White,et al.  [Letters to nature] , 1975, Nature.

[147]  I. Merchenthaler,et al.  Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. , 1996, Endocrinology.

[148]  P. Hellström,et al.  Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects , 2004, British Journal of Nutrition.

[149]  J. A. Fernández-Represa,et al.  Peptide YY Secretion in Morbidly Obese Patients Before and After Vertical Banded Gastroplasty , 2002, Obesity surgery.

[150]  R. Cone,et al.  Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. , 2004, Endocrinology.

[151]  S. Woods,et al.  Leptin Increases Hypothalamic Pro-opiomelanocortin mRNA Expression in the Rostral Arcuate Nucleus , 1997, Diabetes.

[152]  S. Woods,et al.  Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. , 1984, The American journal of physiology.

[153]  E. Ravussin,et al.  Role of ghrelin polymorphisms in obesity based on three different studies. , 2002, Obesity research.

[154]  T. Sakurai,et al.  Ghrelin-induced food intake is mediated via the orexin pathway. , 2003, Endocrinology.

[155]  H. Yoshimatsu,et al.  Hypothalamic Melanocortin System Regulates Sympathetic Nerve Activity in Brown Adipose Tissue , 2004, Experimental biology and medicine.

[156]  B. Morris.  Neuronal localisation of neuropeptide Y gene expression in rat brain , 1989, The Journal of comparative neurology.

[157]  H. Sul.  Resistin/ADSF/FIZZ3 in obesity and diabetes , 2004, Trends in Endocrinology & Metabolism.

[158]  A. Levine,et al.  Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. , 1991, The American journal of physiology.

[159]  B. McEwen,et al.  Acute stress increases neuropeptide Y mRNA within the arcuate nucleus and hilus of the dentate gyrus. , 2000, Brain research. Molecular brain research.

[160]  T. Blundell,et al.  Conformational flexibility in a small globular hormone: X‐ray analysis of avian pancreatic polypeptide at 0.98‐Å resolution , 1983, Biopolymers.

[161]  B. Lowell,et al.  Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. , 1995, The Journal of clinical investigation.

[162]  P. Urios,et al.  Cyclic guanosylmonophosphate urinary excretion in parasympathicomimetic or parasympatholytic syndromes induced by reserpine or diphemanil-methylsulfate. , 1998, Life sciences.

[163]  A. Kirchgessner,et al.  Orexin Synthesis and Response in the Gut , 1999, Neuron.

[164]  T. Arima,et al.  Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. , 2002, Diabetes.

[165]  E. Abel.  Cannabis: effects on hunger and thirst. , 1975, Behavioral biology.

[166]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[167]  K. Kangawa,et al.  A transient surge of ghrelin secretion before feeding is modified by different feeding regimens in sheep. , 2002, Biochemical and biophysical research communications.

[168]  Jiwen Jiang,et al.  Stable expression of the rat GLP-I receptor in CHO cells: Activation and binding characteristics utilizing GLP-I(7–36)-amide, oxyntomodulin, exendin-4, and exendin(9–39) , 1994, Peptides.

[169]  S. O’Rahilly,et al.  Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. , 2000, The Journal of clinical investigation.

[170]  R. Jensen,et al.  Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[171]  Clifford B. Saper,et al.  Unraveling the central nervous system pathways underlying responses to leptin , 1998, Nature Neuroscience.

[172]  John T. Clark,et al.  Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY , 1987, Regulatory Peptides.

[173]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[174]  K. Hosoda,et al.  Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. , 2001, Diabetes.

[175]  Stephen R. Bloom,et al.  Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression , 1998, Nature.

[176]  K. Kangawa,et al.  Weight loss increases circulating levels of ghrelin in human obesity , 2002, Clinical endocrinology.

[177]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[178]  T. Sakurai,et al.  Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia , 1999, Neuroscience Letters.

[179]  S. Carr,et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.

[180]  G. Schwartz,et al.  A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[181]  R. Cone,et al.  Integration of NPY, AGRP, and Melanocortin Signals in the Hypothalamic Paraventricular Nucleus Evidence of a Cellular Basis for the Adipostat , 1999, Neuron.

[182]  J. Kelly,et al.  GABA and hypothalamic feeding systems. I. Topographic analysis of the effects of microinjections of muscimol , 1979, Physiology & Behavior.

[183]  K. Grove,et al.  Orexin Neurons Express a Functional Pancreatic Polypeptide Y4 Receptor , 2003, The Journal of Neuroscience.

[184]  A. N. van den Pol,et al.  Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.

[185]  D. Carling,et al.  AMP-activated Protein Kinase Plays a Role in the Control of Food Intake* , 2004, Journal of Biological Chemistry.

[186]  L. V. D. van der Ploeg,et al.  Evidence of altered hypothalamic pro-opiomelanocortin/ neuropeptide Y mRNA expression in tubby mice. , 1998, Brain research. Molecular brain research.

[187]  E. Dellinger,et al.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.

[188]  E. Air,et al.  The Catabolic Action of Insulin in the Brain Is Mediated by Melanocortins , 2002, The Journal of Neuroscience.

[189]  R. Coffey,et al.  Stimulatory actions of insulin-like growth factor-I and transforming growth factor-alpha on intestinal neurotensin and peptide YY. , 1999, Endocrinology.

[190]  T. Moran,et al.  Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[191]  Philippe Froguel,et al.  Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. , 2003, Human molecular genetics.

[192]  Mohammad A Ghatei,et al.  Oxyntomodulin suppresses appetite and reduces food intake in humans. , 2003, The Journal of clinical endocrinology and metabolism.

[193]  S. P. Grossman,et al.  Chronic intrahypothalamic infusions of insulin or insulin antibodies alter body weight and food intake in the rat , 1992, Physiology & Behavior.

[194]  E. Theodorsson,et al.  Plasma concentrations of regulatory peptides in obseity following modified sham feeding (MSF) and a liquid test meal , 1992, Regulatory Peptides.

[195]  G. Barsh,et al.  Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area , 1998, The Journal of comparative neurology.

[196]  A. Asakawa,et al.  Roles of pancreatic polypeptide in regulation of food intake , 2002, Peptides.

[197]  J. Flier,et al.  Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[198]  M. Stock,et al.  Anorectic actions of prolactin-releasing peptide are mediated by corticotropin-releasing hormone receptors. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[199]  A. Inui,et al.  Motilin is a biosignal controlling cyclic release of pancreatic polypeptide via the vagus in fasted dogs. , 1997, The American journal of physiology.

[200]  J. Olney.  Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate , 1969, Science.

[201]  A. Tanswell,et al.  Bronchial epithelium-associated pulmonary arterial muscle relaxation in the rat is absent in the fetus and suppressed by postnatal hypoxia. , 2005, American Journal of Physiology - Lung cellular and Molecular Physiology.

[202]  Noboru Murakami,et al.  The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. , 2002, Gastroenterology.

[203]  P. Widdowson,et al.  Regulation of Neuropeptide Y Release by Neuropeptide Y Receptor Ligands and Calcium Channel Antagonists in Hypothalamic Slices , 1999, Journal of neurochemistry.

[204]  C. Inagaki,et al.  GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. , 2001, The Journal of clinical endocrinology and metabolism.

[205]  F. Sundler,et al.  Distribution of pancreatic polypeptide and peptide YY , 2002, Peptides.

[206]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[207]  A. Kelley,et al.  Evidence of a Functional Relationship between the Nucleus Accumbens Shell and Lateral Hypothalamus Subserving the Control of Feeding Behavior , 1999, The Journal of Neuroscience.

[208]  W. Goodman,et al.  Role of the calcium-sensing receptor in parathyroid gland physiology. , 2004, American journal of physiology. Renal physiology.

[209]  L. Bellinger,et al.  The lateral hypothalamic area revisited: Ingestive behavior , 1996, Neuroscience & Biobehavioral Reviews.

[210]  S. Woods,et al.  Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons , 1979, Nature.

[211]  C. Plata-salamán,et al.  Feeding Response to Neuropeptide Y-Related Compounds in Rats Treated With Y5 Receptor Antisense or Sense Phosphothio-oligodeoxynucleotide , 1999, Physiology & Behavior.

[212]  M. Fujimiya,et al.  Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. , 2003, Gastroenterology.

[213]  M. Nakazato,et al.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. , 2000, Endocrinology.

[214]  J. Kelly,et al.  GABA and hypothalamic feeding systems , 1979, Brain Research Bulletin.

[215]  Adam Drewnowski,et al.  Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement , 1992, Physiology & Behavior.

[216]  G. P. Smith,et al.  Abdominal vagotomy does not block the satiety effect of bombesin in the rat , 1981, Peptides.

[217]  L. Bellinger,et al.  The dorsomedial hypothalamic nucleus revisited: 1986 update , 1987, Brain Research Reviews.

[218]  Jacqueline N. Crawley,et al.  Biological actions of cholecystokinin , 1994, Peptides.

[219]  D. Chapelot,et al.  Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. , 2004, American journal of physiology. Endocrinology and metabolism.

[220]  E. H. Goulding,et al.  Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor , 2003, Nature Neuroscience.

[221]  F. Chehab,et al.  Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin , 1996, Nature Genetics.

[222]  X. Cai,et al.  Hypothalamic orexin expression: modulation by blood glucose and feeding. , 1999, Diabetes.

[223]  S. Mojsov,et al.  Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences , 1995, FEBS letters.

[224]  L. Swanson,et al.  Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus , 1985, The Journal of comparative neurology.

[225]  Cai Li,et al.  Generation of Soluble Leptin Receptor by Ectodomain Shedding of Membrane-spanning Receptors in Vitro and in Vivo * , 2002, The Journal of Biological Chemistry.

[226]  S. Toubro,et al.  The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction , 2001, International Journal of Obesity.

[227]  R. Hill,et al.  The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin , 1988, British journal of pharmacology.

[228]  T. Adrian,et al.  Release of gastrointestinal hormones following an oral water load , 1979, Experientia.

[229]  T. Adrian,et al.  Distribution and release of human pancreatic polypeptide. , 1976, Gut.

[230]  G. Gessa,et al.  Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. , 1998, Life sciences.

[231]  J. Reeve,et al.  Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology. , 1994, Annals of the New York Academy of Sciences.

[232]  M. Tschöp,et al.  Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. , 2001, European journal of endocrinology.

[233]  D L Hay,et al.  Oxyntomodulin inhibits food intake in the rat. , 2001, Endocrinology.

[234]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[235]  Mohammad A Ghatei,et al.  Peripheral oxyntomodulin reduces food intake and body weight gain in rats. , 2004, Endocrinology.

[236]  K. Ellacott,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society PRL-Releasing Peptide Reduces Food Intake and May Mediate Satiety Signaling , 2022 .

[237]  Paul R. McHugh,et al.  Two brain cholecystokinin receptors: implications for behavioral actions , 1986, Brain Research.

[238]  J. Jahng,et al.  Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[239]  J. Holst.  Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors , 2004, Expert opinion on emerging drugs.

[240]  S. Woods,et al.  Insulin in the brain: a hormonal regulator of energy balance. , 1992, Endocrine reviews.

[241]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[242]  K. Hosoda,et al.  Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[243]  E. Air,et al.  Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity , 2002, Nature Medicine.

[244]  J. Mcdonald,et al.  Neuropeptide Y: Direct and indirect action on insulin secretion in the rat , 1985, Peptides.

[245]  A. Astrup,et al.  The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity , 2001, International Journal of Obesity.

[246]  S. Boyer,et al.  Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats. , 2002, Diabetes.

[247]  S. Leibowitz,et al.  The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s) , 1993, Brain Research.

[248]  A. N. van den Pol,et al.  Synaptic Interaction between Hypocretin (Orexin) and Neuropeptide Y Cells in the Rodent and Primate Hypothalamus: A Novel Circuit Implicated in Metabolic and Endocrine Regulations , 1999, The Journal of Neuroscience.

[249]  J. Rehfeld,et al.  Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. , 1996, Scandinavian journal of clinical and laboratory investigation.

[250]  A. Bannon,et al.  Behavioral characterization of neuropeptide Y knockout mice , 2000, Brain Research.

[251]  W. Rand,et al.  Agouti-related protein (AGRP) has a central inhibitory action on the hypothalamic-pituitary-thyroid (HPT) axis; comparisons between the effect of AGRP and neuropeptide Y on energy homeostasis and the HPT axis. , 2002, Endocrinology.

[252]  J. Flier,et al.  Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3 , 2004, Nature Medicine.

[253]  K. Clément,et al.  A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction , 1998, Nature.

[254]  S. Bloom,et al.  The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. , 2000, The Journal of clinical investigation.

[255]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[256]  W. Drake,et al.  A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal. , 2002, The Journal of clinical endocrinology and metabolism.

[257]  G. Bray,et al.  Afferent signals regulating food intake , 2000, Proceedings of the Nutrition Society.

[258]  J. Holst,et al.  Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients , 1993, Diabetologia.

[259]  Michael W. Schwartz,et al.  Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons , 1998, Nature Neuroscience.

[260]  T. Adrian,et al.  Effects of peptide YY and neuropeptide Y on gastric emptying in man. , 1984, Digestion.

[261]  S. O’Rahilly,et al.  Induction of Adipocyte Complement-related Protein of 30 Kilodaltons by Ppar␥ Agonists: a Potential Mechanism of Insulin Sensitization , 2022 .

[262]  M. Matsuda,et al.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.

[263]  G. Sanacora,et al.  Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. , 1990, Endocrinology.

[264]  S. Woods,et al.  Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[265]  H. Klonowski-Stumpe,et al.  Long-Term Effects of CCK-Agonist and -Antagonist on Food Intake and Body Weight in Zucker Lean and Obese Rats , 1998, Peptides.

[266]  H. Pijl,et al.  Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. , 2003, Diabetes, nutrition & metabolism.

[267]  M. G. Dube,et al.  Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[268]  R. Palmiter,et al.  Dopamine Production in the Caudate Putamen Restores Feeding in Dopamine-Deficient Mice , 2001, Neuron.

[269]  H. Blau,et al.  Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. , 2003, European journal of pharmacology.

[270]  K. Clément,et al.  Molecular Genetics of Human Obesity‐Associated MC4R Mutations , 2003, Annals of the New York Academy of Sciences.

[271]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[272]  E. Blázquez,et al.  Autoradiographic localization of receptors for glucagon-like peptide-1(7–36) amide in rat brain , 1992, Neuropeptides.

[273]  S. Rössner,et al.  Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. , 1999, International Journal of Obesity.

[274]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[275]  Yue Feng,et al.  Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[276]  C. V. van Noorden,et al.  The multifunctional or moonlighting protein CD26/DPPIV. , 2003, European journal of cell biology.

[277]  S. Woods,et al.  Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. , 1996, The American journal of physiology.

[278]  H. Akil,et al.  The presence of two α-MSH positive cell groups in rat hypothalamus , 1979 .

[279]  D. Kuo.  Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats. , 2002, Journal of biomedical science.

[280]  S. Woods,et al.  Insulin and the blood-brain barrier. , 2003, Current pharmaceutical design.

[281]  R. Palmiter,et al.  Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues , 1999, Brain Research.

[282]  D. Allison,et al.  Physiology: Does gut hormone PYY3–36 decrease food intake in rodents? , 2004, Nature.

[283]  M. Matsubara,et al.  Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract , 2002, Peptides.

[284]  C. Bouchard,et al.  A polymorphism in the human agouti-related protein is associated with late-onset obesity. , 2002, The Journal of clinical endocrinology and metabolism.

[285]  Jesús García,et al.  Dissociation of charge movement from calcium release and calcium current in skeletal myotubes by gabapentin. , 2002, American journal of physiology. Cell physiology.

[286]  J. Holst,et al.  Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity , 1997, International Journal of Obesity.

[287]  S. Honma,et al.  Effects of restricted daily feeding on neuropeptide Y release in the rat paraventricular nucleus. , 1996, The American journal of physiology.

[288]  R. Cone,et al.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. , 2000, Endocrinology.

[289]  M. Schwartz,et al.  Intracellular signalling: Key enzyme in leptin-induced anorexia , 2001, Nature.

[290]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[291]  T. Crow,et al.  Neuropeptide Y distribution in the rat brain. , 1983, Science.

[292]  M. Ghatei,et al.  Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. , 1993, Endocrinology.

[293]  D. York,et al.  Acute changes in the response to peripheral leptin with alteration in the diet composition. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[294]  R. Palmiter,et al.  Role of the Y5 neuropeptide Y receptor in feeding and obesity , 1998, Nature Medicine.

[295]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[296]  A. Yamanaka,et al.  Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight , 1999, Brain Research.

[297]  J. Friedman,et al.  Abnormal splicing of the leptin receptor in diabetic mice , 1996, Nature.

[298]  Y. Deshaies,et al.  A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. , 2004, Endocrinology.

[299]  S. Whitebread,et al.  Inhibition of Food Intake by Neuropeptide Y Y5 Receptor Antisense Oligodeoxynucleotides , 1997, Diabetes.

[300]  J. Brobeck,et al.  Localization of a “Feeding Center” in the Hypothalamus of the Rat , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[301]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[302]  W. Zipf,et al.  Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome. , 1981, The Journal of clinical endocrinology and metabolism.

[303]  S. Woods,et al.  Metabolic hormones and regulation of body weight. , 1974, Psychological review.

[304]  S. Bloom,et al.  PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. , 2001, Endocrinology.

[305]  Michael B Wheeler,et al.  The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. , 2002, Diabetes.

[306]  D. Porte,et al.  Localization of insulin receptor mRNA in rat brain by in situ hybridization. , 1990, Endocrinology.

[307]  K. Fukui,et al.  Light and electron microscopic immunocytochemistry of neurotensin-like immunoreactive neurons in the rat hypothalamus , 1984, Brain Research.

[308]  T. Tai,et al.  Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.

[309]  W. Pan,et al.  Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier , 2002, Journal of Molecular Neuroscience.

[310]  C. Saper,et al.  Distributions of leptin receptor mRNA isoforms in the rat brain , 1998, The Journal of comparative neurology.

[311]  R. Broadwell,et al.  Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood , 1976, The Journal of comparative neurology.

[312]  J. Habener,et al.  Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. , 1996, Endocrinology.

[313]  T. Adrian,et al.  Effect of peptide YY on gastric, pancreatic, and biliary function in humans. , 1985, Gastroenterology.

[314]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[315]  F. Rohner-Jeanrenaud,et al.  Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. , 1993, Endocrinology.

[316]  P. Blache,et al.  Oxyntomodulin-like immunoreactivity: diurnal profile of a new potential enterogastrone. , 1992, The Journal of clinical endocrinology and metabolism.

[317]  S. Woods,et al.  Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats , 1998, Brain Research.

[318]  M. Gregor,et al.  Gut hormones in tropical malabsorption. , 1979, British medical journal.

[319]  J. Crawley,et al.  Rapid development of tolerance to the behavioural actions of cholecystokinin , 1983, Nature.

[320]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[321]  H. Berthoud,et al.  Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[322]  G. Schwartz,et al.  CCK Elicits and Modulates Vagal Afferent Activity Arising from Gastric and Duodenal Sites , 1994, Annals of the New York Academy of Sciences.

[323]  P. Boer,et al.  Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat , 1989, Neuroscience.

[324]  V. Pickel,et al.  Ultrastructural localization of neuropeptide Y Y1 receptors in the rat medial nucleus tractus solitarius: Relationships with neuropeptide Y or catecholamine neurons , 2002, Journal of neuroscience research.

[325]  S. Bloom,et al.  Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure , 2002, International Journal of Obesity.

[326]  M. Low,et al.  Activation of Central Melanocortin Pathways by Fenfluramine , 2002, Science.

[327]  P. Emson,et al.  Electrical activation and c‐fos mRNA expression in rat neurosecretory neurones after systemic administration of cholecystokinin. , 1991, The Journal of physiology.

[328]  I. McGregor,et al.  Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. , 2004, Endocrinology.

[329]  T. Hökfelt,et al.  Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[330]  W. Banks,et al.  Leptin enters the brain by a saturable system independent of insulin , 1996, Peptides.

[331]  R. Seeley,et al.  The Diverse Roles of Specific GLP-1 Receptors in the Control of Food Intake and the Response to Visceral Illness , 2002, The Journal of Neuroscience.

[332]  D. Driscoll.  Polycystic Ovary Syndrome in Adolescence , 2003, Seminars in reproductive medicine.

[333]  J. Galmiche,et al.  Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut , 1997, Pflügers Archiv.

[334]  R. Agami,et al.  Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake , 2002, BMC Neuroscience.

[335]  W. Banks,et al.  Characterization of Blood-Brain Barrier Permeability to PYY3-36 in the Mouse , 2003, Journal of Pharmacology and Experimental Therapeutics.

[336]  P. Widdowson,et al.  Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release. , 2000, European journal of pharmacology.

[337]  A. Yoshimura,et al.  Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity , 2004, Nature Medicine.

[338]  Yuxiang Sun,et al.  Deletion of Ghrelin Impairs neither Growth nor Appetite , 2003, Molecular and Cellular Biology.

[339]  J. Koch.  Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. , 2001, Pharmacology, biochemistry, and behavior.

[340]  L. Bednarz,et al.  Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats , 1992, Brain Research.

[341]  R. Atkinson,et al.  Appetite suppressant activity in plasma of rats after intestinal bypass surgery. , 1982, The American journal of physiology.

[342]  A. Inui,et al.  Neuropeptide Y feeding receptors: are multiple subtypes involved? , 1999, Trends in pharmacological sciences.

[343]  N. Rowland,et al.  Metering of intravenous versus oral nutrients and regulation of energy balance. , 1976, The American journal of physiology.

[344]  S. Bloom,et al.  Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract. , 1983, The Journal of clinical endocrinology and metabolism.

[345]  A. Kelley,et al.  Nucleus accumbens opioid, GABaergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat. , 2003, Behavioral neuroscience.

[346]  A. Geliebter,et al.  Cholecystokinin and stomach distension combine to reduce food intake in humans. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[347]  K. Chihara,et al.  Ghrelin Modulates the Downstream Molecules of Insulin Signaling in Hepatoma Cells* , 2002, The Journal of Biological Chemistry.

[348]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[349]  J. Darnell,et al.  Leptin activation of Stat3 in the hypothalamus of wild–type and ob/ob mice but not db/db mice , 1996, Nature Genetics.

[350]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[351]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[352]  G. Bray,et al.  Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. , 1991, The American journal of physiology.

[353]  R. Steiner,et al.  Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. , 1997, Endocrinology.

[354]  Beth Borowsky,et al.  Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist , 2002, Nature Medicine.

[355]  P. Sawchenko.  Central connections of the sensory and motor nuclei of the vagus nerve. , 1983, Journal of the autonomic nervous system.

[356]  A. G. Roseberry,et al.  Neuropeptide Y-Mediated Inhibition of Proopiomelanocortin Neurons in the Arcuate Nucleus Shows Enhanced Desensitization in ob/ob Mice , 2004, Neuron.

[357]  F. Leslie,et al.  Expression of the melanin‐concentrating hormone (MCH) receptor mRNA in the rat brain , 2001, The Journal of comparative neurology.

[358]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[359]  L H Schneider,et al.  Orosensory Self‐Stimulation by Sucrose Involves Brain Dopaminergic Mechanisms a , 1989, Annals of the New York Academy of Sciences.

[360]  S. Leibowitz,et al.  Feeding and drinking elicited by central injection of neuropeptide Y: Evidence for a hypothalamic site(s) of action , 1985, Brain Research Bulletin.

[361]  R. Lechan,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Agouti-Related Protein Containing Nerve Terminals Innervate Thyrotropin-Releasing Hormone Neurons in , 1999 .

[362]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[363]  W. Hopman,et al.  Effect of circulating peptide YY on gallbladder emptying in humans. , 2001, Scandinavian journal of gastroenterology.

[364]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[365]  P S Kalra,et al.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. , 1984, Endocrinology.

[366]  M. Nakazato,et al.  Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. , 2000, Biochemical and biophysical research communications.

[367]  A. Astrup,et al.  A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[368]  C. Saper,et al.  Leptin activates neurons in ventrobasal hypothalamus and brainstem. , 1997, Endocrinology.

[369]  M. Kuhar,et al.  Further studies on the anatomical distribution of CART by in situ hybridization , 1997, Journal of Chemical Neuroanatomy.

[370]  H. Akil,et al.  The presence of two alpha-MSH positive cell groups in rat hypothalamus. , 1979, European journal of pharmacology.

[371]  M. G. Dube,et al.  Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. , 2002, Endocrinology.

[372]  L. Perrone,et al.  Molecular screening of the ghrelin gene in Italian obese children: the Leu72Met variant is associated with an earlier onset of obesity , 2004, International Journal of Obesity.

[373]  R. Cone,et al.  A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse. , 2000, Endocrinology.

[374]  A. Weerth,et al.  The brain and gastrointestinal cholecystokinin receptor family; structure and functional expression , 1992, Regulatory Peptides.

[375]  K. Nakao,et al.  Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans , 1997, Nature Medicine.

[376]  P. Hoogerhout,et al.  Distribution of Lys-γ2-melanocyte-stimulating hormone-(Lys-γ2-MSH)-like immunoreactivity in neuronal elements in the brain and peripheral tissues of the rat , 1996, Brain Research.

[377]  J Dixon,et al.  Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[378]  Henry C. Lin,et al.  Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs , 2003, Regulatory Peptides.

[379]  Gold,et al.  Differential Regulation of Neuropeptide Y mRNA Expression in the Arcuate Nucleus and Locus Coeruleus by Stress and Antidepressants , 2000, Journal of neuroendocrinology.

[380]  J. Holst,et al.  Diurnal profile of pancreatic polypeptide and gut glucagon in human morbid obesity , 1983, Regulatory Peptides.

[381]  P. Morgan,et al.  Coexpression of Leptin Receptor and Preproneuropeptide Y mRNA in Arcuate Nucleus of Mouse Hypothalamus , 1996, Journal of neuroendocrinology.

[382]  G. Szmukler,et al.  Potential regulators of feeding behavior in anorexia nervosa. , 1992, The American journal of clinical nutrition.

[383]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[384]  J M Polak,et al.  Human distribution and release of a putative new gut hormone, peptide YY. , 1985, Gastroenterology.

[385]  E. Rolls,et al.  Bombesin suppresses feeding in rats , 1979, Nature.

[386]  A. Andersen,et al.  Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. , 1979, Scandinavian journal of gastroenterology.

[387]  B. Spiegelman,et al.  AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.

[388]  D. Macneil,et al.  Neither Agouti-Related Protein nor Neuropeptide Y Is Critically Required for the Regulation of Energy Homeostasis in Mice , 2002, Molecular and Cellular Biology.

[389]  G. Berntson,et al.  Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome , 1993, Peptides.

[390]  A. Bado,et al.  The stomach is a source of leptin , 1998, Nature.

[391]  J. A. Ricardo,et al.  Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat , 1978, Brain Research.

[392]  T. Arima,et al.  Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion , 2002 .

[393]  P. Froguel,et al.  A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. , 2002, The Journal of clinical endocrinology and metabolism.

[394]  R. Darnell,et al.  Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[395]  J. Rehfeld,et al.  Distribution of gastrin and CCK cells in the rat gastrointestinal tract , 1978, Histochemistry.

[396]  T. Hökfelt,et al.  Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. , 1997, Neuroendocrinology.

[397]  D. Cummings,et al.  Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. , 2004, The Journal of clinical endocrinology and metabolism.

[398]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[399]  M. Kalia,et al.  Brainstem projections of sensory and motor components of the vagus nerve in the rat , 1982, The Journal of comparative neurology.

[400]  J. Flier,et al.  Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. , 2000, The Journal of clinical investigation.

[401]  N. Morin,et al.  Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. , 2000, Endocrinology.

[402]  R. Palmiter,et al.  Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression. , 2004, Endocrinology.

[403]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[404]  D. Whitcomb,et al.  Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain. , 1990, The American journal of physiology.

[405]  Shelagh Wilson,et al.  Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat , 1999, Peptides.

[406]  Terry D. Lee,et al.  A new molecular form of PYY: Structural characterization of human PYY(3–36) and PYY(1–36) , 1989, Peptides.

[407]  A. Argiolas,et al.  Differential Orexigenic Effects of Hexarelin and Its Analogs in the Rat Hypothalamus: Indication for Multiple Growth Hormone Secretagogue Receptor Subtypes , 2000, Neuroendocrinology.

[408]  M. Birnbaum,et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.

[409]  C. Saper,et al.  Leptin Activates Hypothalamic CART Neurons Projecting to the Spinal Cord , 1998, Neuron.

[410]  J. Holst,et al.  GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. , 1999, The American journal of physiology.

[411]  N. Jamshidi,et al.  Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats , 2001, British journal of pharmacology.

[412]  R. Seeley,et al.  A Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences , 2000, The Journal of Neuroscience.

[413]  G. P. Smith,et al.  C-terminal octapeptide of cholecystokinin decreases food intake in man. , 1981, The American journal of clinical nutrition.

[414]  F E Bloom,et al.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[415]  P. Lambert,et al.  c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y , 1995, Brain Research.

[416]  R. J. Crosby,et al.  Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers , 1990, Brain Research.

[417]  M. Fujimiya,et al.  Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice☆ , 1999, Peptides.

[418]  K. Moar,et al.  Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. , 1998, Endocrinology.

[419]  M. Soares,et al.  Distribution of prolactin-releasing peptide mRNA in the rat brain , 2000, Brain Research Bulletin.

[420]  T. Lutz,et al.  Peptide YY Directly Inhibits Ghrelin-Activated Neurons of the Arcuate Nucleus and Reverses Fasting-Induced c-Fos Expression , 2004, Neuroendocrinology.

[421]  E. Straus,et al.  Fasting- and meal-stimulated peptide hormone concentrations before and after gastric surgery for morbid obesity. , 1986, Metabolism: clinical and experimental.

[422]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[423]  J. Reeve,et al.  Natural and Synthetic CCK‐58 , 1994 .

[424]  R. Ritter,et al.  Cholecystokinin and leptin act synergistically to reduce body weight. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[425]  W. Zipf,et al.  Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome. , 1983, The Journal of clinical endocrinology and metabolism.

[426]  Kent C. Berridge,et al.  Modulation of taste affect by hunger, caloric satiety, and sensory-specific satiety in the rat , 1991, Appetite.

[427]  H. Kannan,et al.  Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[428]  C. Lawrence,et al.  Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. , 2002, Endocrinology.

[429]  C. Strader,et al.  Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats. , 1998, Obesity research.

[430]  D. Smith,et al.  Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. , 2000, Diabetes.

[431]  P. Maćkowiak,et al.  Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. , 1999, Life sciences.

[432]  I. Goldfine,et al.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. , 1985, The Journal of clinical investigation.

[433]  G. Schwartz,et al.  Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. , 1997, The American journal of physiology.

[434]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[435]  R. Carraway,et al.  Evidence that neurotensin mediates the central effect of leptin on food intake in rat , 2001, Brain Research.

[436]  T. Hökfelt,et al.  Regulation of expression of neuropeptide Y Y1 and Y2 receptors in the arcuate nucleus of fasted rats , 1998, Brain Research.

[437]  J. Holst,et al.  Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study , 2002, The Lancet.

[438]  M. Low,et al.  The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis , 2001, International Journal of Obesity.

[439]  J. Strubbe,et al.  Increased feeding in response to bilateral injection of insulin antibodies in the VMH , 1977, Physiology & Behavior.

[440]  A. Masclee,et al.  Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism. , 1993, The Journal of clinical endocrinology and metabolism.

[441]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[442]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[443]  S. Woods,et al.  Suppression of food intake by intravenous nutrients and insulin in the baboon. , 1984, The American journal of physiology.

[444]  D O'Shea,et al.  Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. , 1999, Endocrinology.

[445]  William A Banks,et al.  The source of cerebral insulin. , 2004, European journal of pharmacology.

[446]  J. Powell,et al.  An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat , 1985, Brain Research.

[447]  Å. Lindström,et al.  Ornithology: Arctic waders are not capital breeders , 2001, Nature.

[448]  G. P. Smith,et al.  Cholecystokinin decreases food intake in rats. , 1973, Journal of comparative and physiological psychology.

[449]  B. Stoffel‐Wagner.  Neurosteroid metabolism in the human brain. , 2001, European journal of endocrinology.

[450]  F. Buonomo,et al.  Effect of CCK antibodies on food intake and weight gain in zucker rats , 1985, Physiology & Behavior.

[451]  F E Bloom,et al.  The organization of projections from the cortes, amygdala, and hypothalamus to the nucleus of the solitary tract in rat , 1984, The Journal of comparative neurology.

[452]  S. Woods,et al.  Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[453]  Zhaohui Feng,et al.  Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats , 2002, Nature Neuroscience.

[454]  P. J. Larsen,et al.  Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. , 1998, Diabetes.

[455]  D. Smith,et al.  Neuropeptide Y Induced Feeding in the Rat Is Mediated by a Novel Receptor1. , 1997, Endocrinology.

[456]  A. Sahu,et al.  Resistance to the Satiety Action of Leptin Following Chronic Central Leptin Infusion is Associated with the Development of Leptin Resistance in Neuropeptide Y Neurones , 2002, Journal of neuroendocrinology.

[457]  Clifford B Saper,et al.  Leptin Differentially Regulates NPY and POMC Neurons Projecting to the Lateral Hypothalamic Area , 1999, Neuron.

[458]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[459]  V. Marks,et al.  Attenuated GLP-1 secretion in obesity: cause or consequence? , 1996, Gut.

[460]  Michael Esterman,et al.  The Distribution and Mechanism of Action of Ghrelin in the CNS Demonstrates a Novel Hypothalamic Circuit Regulating Energy Homeostasis , 2003, Neuron.

[461]  C Cobelli,et al.  Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. , 1993, The Journal of clinical investigation.

[462]  M. Berelowitz,et al.  Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. , 1990, Endocrinology.

[463]  S. Kalra,et al.  Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake , 1998, Physiology & Behavior.

[464]  A. Levine,et al.  Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands , 1998, Brain Research.

[465]  D. Drucker,et al.  Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites , 2003, The Journal of Neuroscience.

[466]  P S Kalra,et al.  Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. , 1999, Endocrine reviews.

[467]  P. Hoogerhout,et al.  Distribution of Lys-gamma 2-melanocyte-stimulating hormone- (Lys-gamma 2-MSH)-like immunoreactivity in neuronal elements in the brain and peripheral tissues of the rat. , 1996, Brain research.

[468]  Y. Taché,et al.  Peripheral ghrelin selectively increases Fos expression in neuropeptide Y – synthesizing neurons in mouse hypothalamic arcuate nucleus , 2002, Neuroscience Letters.

[469]  W. Rand,et al.  a-Melanocyte-Stimulating Hormone Is Contained in Nerve Terminals Innervating Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus and Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Gene Expression , 2000 .

[470]  J. Wakerley,et al.  Central oxytocin potentiates excitatory responses of oxytocin neurones to stimulation of the dorsomedial hypothalamic nucleus in the suckled rat , 2002, Neuroscience Letters.

[471]  M. Peracchi,et al.  Plasma pancreatic polypeptide response to secretin. , 1999, European journal of endocrinology.

[472]  N. Ling,et al.  The distribution and projection of γ-melanocyte stimulating hormone in the rat brain: An immunohistochemical analysis , 1984, Brain Research.

[473]  S. Bloom,et al.  Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. , 2001, Diabetes.

[474]  J. Holst.  Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential , 1999, Trends in Endocrinology & Metabolism.

[475]  M. Mortrud,et al.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. , 1994, Molecular endocrinology.

[476]  H. Lodish,et al.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[477]  R. Buckingham,et al.  Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat , 1997, Brain Research.

[478]  S. Bloom,et al.  The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. , 2000, Endocrinology.

[479]  Y. Smith,et al.  CART peptides in the central control of feeding and interactions with neuropeptide Y , 1998, Synapse.

[480]  B. Khoo,et al.  A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes , 2003, The Lancet.

[481]  K. Ellacott,et al.  Repeated administration of the anorectic factor prolactin-releasing peptide leads to tolerance to its effects on energy homeostasis. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.